# Renal Denervation on Quality of 24-hr BP Control by Ultrasound In Resistant Hypertension

Study · id `cardio:ct-nct02918305` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02918305](<https://clinicaltrials.gov/study/NCT02918305>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02918305

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It plans to enroll 140 participants.

## Technical summary

Registry record NCT02918305. Randomized; double masking; primary purpose treatment. Start 2017-01 (actual); primary completion 2020-07 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 140 participants (planned count; ClinicalTrials.gov record NCT02918305, source copy `cardio:ctgov-nct02918305-2021-11-19`, retrieved 2026-10-26)
- Started: 2017-01 (actual) (ClinicalTrials.gov record NCT02918305, source copy `cardio:ctgov-nct02918305-2021-11-19`, retrieved 2026-10-26)
- Primary completion: 2020-07 (actual) (ClinicalTrials.gov record NCT02918305, source copy `cardio:ctgov-nct02918305-2021-11-19`, retrieved 2026-10-26)
- Completion: 2021-10 (actual) (ClinicalTrials.gov record NCT02918305, source copy `cardio:ctgov-nct02918305-2021-11-19`, retrieved 2026-10-26)
- Countries: Japan; South Korea (ClinicalTrials.gov record NCT02918305, source copy `cardio:ctgov-nct02918305-2021-11-19`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02918305-2021-11-19`, retrieved 2026-10-26)

## The registry's words

- Brief title: Renal Denervation on Quality of 24-hr BP Control by Ultrasound In Resistant Hypertension
- Acronym: REQUIRE
- Condition: Hypertension
- Condition: Vascular Diseases
- Intervention (Device): PRDS-001 Renal Denervation Ultrasound System
- Intervention (Procedure): Sham Procedure
- Lead sponsor: JIMRO Co., Ltd.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Resistant hypertension (`cardio:resistant-hypertension`)
- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Catheter-based ultrasound renal denervation in patients with resistant hypertension: the randomized, controlled REQUIRE trial (`cardio:pubmed-34654905`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 6c4fbd2d47042aff443b5a217adef5b1ca2b40fb7a8b5dbf809eab76f9e24c3f
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
